Trial Profile
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Dec 2021
Price :
$35
*
At a glance
- Drugs Insulin degludec/liraglutide (Primary) ; Insulin degludec; Liraglutide
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DUAL-I-Japan
- Sponsors Novo Nordisk
- 03 Jan 2018 Status changed from active, no longer recruiting to completed.
- 20 Dec 2017 Planned primary completion date changed from 25 Dec 2017 to 19 Dec 2017.
- 24 Feb 2017 Planned End Date changed from 1 Dec 2017 to 25 Dec 2017.